EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from Bauhinia bauhinioides (pep-BbKI) in an Asthma–COPD Overlap (ACO) Model

Luana Laura Sales da Silva iD, Jéssica Anastácia Silva Barbosa iD, Juliana Morelli Lopes Gonçalves João, Silvia Fukuzaki, Leandro do Nascimento Camargo, Tabata Maruyama Dos Santos, Elaine Cristina de Campos, Arthur Silva Costa, Beatriz Mangueira Saraiva-Romanholo, Suellen Karoline Moreira Bezerra, Fernanda Tenório Quirino Dos Santos Lopes iD, Camila Ramalho Bonturi iD und 4 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Luana Laura Sales da Silva und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 01246-903, Brazil. Hauptthemen laut MEDLINE: Bauhinia, Asthma, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo a Pesquisa do Estado de São Paulo, Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1) There are several patients with asthma–COPD overlap (ACO). A peptide derived from the primary sequence of a kallikrein inhibitor isolated from Bauhinia bauhinioides (pep-BbKI) has potent anti-inflammatory and antioxidant effects. Purpose: To investigate the effects of pep-BbKI treatment in an ACO model and compare them with those of corticosteroids. (2) BALB/c mice were divided into groups: SAL (saline), OVA (ovalbumin), ELA (elastase), ACO (ovalbumin + elastase), ACO-pep-BbKI (treated with inhibitor), ACO-DX (dexamethasone treatment), ACO-DX-pep-BbKI (both treatments), and SAL-pep-BbKI (saline group treated with inhibitor). We evaluated: hyperresponsiveness to methacholine, bronchoalveolar lavage fluid (BALF), exhaled nitric oxide (eNO), IL-1β, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, IFN-γ, TNF-α, MMP-9, MMP-12, TGF-β, collagen fibers, iNOS, eNO, linear mean intercept (Lm), and NF-κB in airways (AW) and alveolar septa (AS). (3) ACO-pep-BbKI reversed ACO alterations and was similar to SAL in all mechanical parameters, Lm, neutrophils, IL-5, IL-10, IL-17, IFN-γ, TNF-α, MMP-12 (AW), collagen fibers, iNOS (AW), and eNO (p > 0.05). ACO-DX reversed ACO alterations and was similar to SAL in all mechanical parameters, Lm, total cells and differentials, IL-1β(AS), IL-5 (AS), IL-6 (AS), IL-10 (AS), IL-13 (AS), IFN-γ, MMP-12 (AS), TGF-β (AS), collagen fibers (AW), iNOS, and eNO (p > 0.05). SAL was similar to SAL-pep-BbKI for all comparisons (p > 0.05). (4) Pep-BbKI was similar to dexamethasone in reducing the majority of alterations of this ACO model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BauhiniaAsthmaPulmonary Disease, Chronic ObstructiveAnimalsMiceInterleukin-10Interleukin-17OvalbuminInterleukin-13Interleukin-5Interleukin-6Matrix Metalloproteinase 12Tumor Necrosis Factor-alphaPlant ProteinsPeptidesBronchoalveolar Lavage FluidKallikreinsPancreatic ElastaseDexamethasoneCollagenDisease Models, AnimalMice, Inbred BALB C

Stichwörter der Autor:innen

ACOBauhiniaairway remodelinginflammationoxidative stressserine proteinase inhibitors

Substanzen

Interleukin-10Interleukin-17OvalbuminInterleukin-13Interleukin-5Interleukin-6Matrix Metalloproteinase 12Tumor Necrosis Factor-alphaPlant ProteinsPeptides

Autor:innen und Institutionen

  • Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 01246-903, Brazil.
  • Department of Medicine, University City of São Paulo, São Paulo 03071-000, Brazil.
  • Departamento de Bioquímica, Universidade Federal de São Paulo (UNIFESP), São Paulo 04039-002, Brazil.
  • Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.

ORCID-Profile: Luana Laura Sales da Silva, Jéssica Anastácia Silva Barbosa, Fernanda Tenório Quirino Dos Santos Lopes, Camila Ramalho Bonturi, Maria Luiza Vilela Oliva, Renato Fraga Righetti

Förderung

  • Fundação de Amparo a Pesquisa do Estado de São Paulo
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Zitieren

APA

Silva, L. L. S. D., Barbosa, J. A. S., João, J. M. L. G., Fukuzaki, S., Camargo, L. D. N., Dos Santos, T. M., Campos, E. C., Costa, A. S., Saraiva-Romanholo, B. M., Bezerra, S. K. M., Lopes, F. T. Q. D. S., Bonturi, C. R., Oliva, M. L. V., Leick, E. A., Righetti, R. F., & Tibério, I. F. L. C. (2023). Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from Bauhinia bauhinioides (pep-BbKI) in an Asthma–COPD Overlap (ACO) Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411261

Vancouver

Silva LLSD, Barbosa JAS, João JMLG, Fukuzaki S, Camargo LDN, Dos Santos TM, et al. Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from Bauhinia bauhinioides (pep-BbKI) in an Asthma–COPD Overlap (ACO) Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411261

BibTeX
@article{Silva2023,
  author = {Silva, Luana Laura Sales da and Barbosa, Jéssica Anastácia Silva and João, Juliana Morelli Lopes Gonçalves and Fukuzaki, Silvia and Camargo, Leandro do Nascimento and Dos Santos, Tabata Maruyama and Campos, Elaine Cristina de and Costa, Arthur Silva and Saraiva-Romanholo, Beatriz Mangueira and Bezerra, Suellen Karoline Moreira and Lopes, Fernanda Tenório Quirino Dos Santos and Bonturi, Camila Ramalho and Oliva, Maria Luiza Vilela and Leick, Edna Aparecida and Righetti, Renato Fraga and Tibério, Iolanda de Fátima Lopes Calvo},
  title = {Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from Bauhinia bauhinioides (pep-BbKI) in an Asthma–COPD Overlap (ACO) Model},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411261}
}
Kostenlos starten →